Suba Krishnan

4.2k citations
19 papers · 3.1k · 2 hit papers · h-index 14

Impact in

  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
  • Genetics top 5%
    • Hemoglobinopathies and Related Disorders
    • Glioma Diagnosis and Treatment

Papers in

    • Hemoglobinopathies and Related Disorders 7
    • Glioma Diagnosis and Treatment 1
    • Cancer Immunotherapy and Biomarkers 7

Suba Krishnan

19 papers receiving 3k citations

Suba Krishnan's Hit Papers

Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE ‐158 and KEYNOTE ‐028 studies 2020 · 391 citations
3910+3+6Years since publication4008001.2k

Peers

Suba Krishnan
Comparison fields: 5 of 71
  • Oncology 1.4k
  • Genetics 309
  • Surgery 1.1k
  • Immunology 185
  • Cancer Research 69
Replace Barbara Jane Klencke with:
Barbara Jane Klencke United States
Yelei Guo China
Alexandre Lambert United States
Laura A. Smit Netherlands
Arvind Chaudhry United States
Eliane Mery-Lamarche France
Thomas Friess Switzerland
Abdel Saci United States
Joan Somja Belgium
Keren A. Coplan United States
Suba Krishnan relative to Barbara Jane Klencke United States Barbara Jane Klencke's profile →
Citations per field
00.5×2×4×5.4×
Barbara Jane Klencke · 1×
Citations per year

Countries citing papers authored by Suba Krishnan

Since Specialization
Citations

This map shows the geographic impact of Suba Krishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suba Krishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suba Krishnan more than expected).

Fields of papers citing papers by Suba Krishnan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suba Krishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suba Krishnan. The network helps show where Suba Krishnan may publish in the future.

Co-authors

The 25 scholars most cited alongside Suba Krishnan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Suba Krishnan Line = papers co-authored together Suba Krishnan links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
Hit paper breakdown →
20171382
2
Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE ‐158 and KEYNOTE ‐028 studies
Hit paper breakdown →
2020391
3 2016349
4 2019309
5 2017156
6 1999141
7 202198
8 200993
9 201264
10 201134
11 200826
12 200319
13 201617
14 199815
15 201611
16 20098
17 19993
18 20102
19 20091

About Suba Krishnan

Suba Krishnan is a scholar working on Genetics, Oncology, Physiology, Nutrition and Dietetics and Hematology, having authored 19 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Hemoglobinopathies and Related Disorders (7 papers), Clinical Laboratory Practices and Quality Control (2 papers), Glioma Diagnosis and Treatment (1 paper), TGF-β signaling in diseases (1 paper), Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper), Bladder and Urothelial Cancer Treatments (1 paper) and S100 Proteins and Annexins (1 paper). The work is most often cited by research in Oncology (1.4k citations), Genetics (309 citations), Surgery (1.1k citations), Immunology (185 citations) and Cancer Research (69 citations). Suba Krishnan has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Katherine A. Hajjar, Xiaotao Qu, Alexandre Lambert, Matthew D. Galsky, Sergio Bracarda, Arlene Odelia Siefker-Radtke, Marc‐Oliver Grimm, Andrea Necchi, Daniel A. Vaena and José Ángel Arranz. Their work appears in journals such as Blood, British Journal of Haematology, Journal for ImmunoTherapy of Cancer, Clinical Chemistry and Clinical Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact